How Corona has changed the regulatory affairs world


"How Corona has changed the regulatory affairs world" organised by Forum Institut für Management will focus on how rolling submissions for Covid-19 vaccines and drugs could affect future innovative medicine registrations.

Experts on regulatory affairs and representatives from vaccine and drug regulators from Germany and Austria will discuss current issues.  

More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.


an initial 10 day temporary access of APM Health Europe.